Department of Gynecologic oncology, Jiangsu Institute of Cancer Research, Nanjing, China.
J Ovarian Res. 2013 Oct 29;6(1):74. doi: 10.1186/1757-2215-6-74.
Oxidative damage and DNA repair dysfunction are associated with carcinogenesis. 8-OHdG is one of the major oxidative DNA adducts. Present work aims to investigate whether the expression of 8-OHdG and its key repair gene hOGG1 play distinctive role in two types of serous ovarian cancer.
8-OHdG level in DNA from tumor and matched tumor-adjacent normal tissue in 48 high-grade papillary serous carcinomas (HG-SOC), 24 low-grade papillary serous carcinomas (LG-SOC), 20 serous cystadenomas, and 16 non-tumor control ovaries was tested. The Cox proportional hazards model and the log-rank test were used to assess the associations between the 8-OHdG level in two types of serous cancer and patients' survival. Real-time polymerase chain reaction and protein immunoblot were employed to detect hOGG1 mRNA and protein levels in tumor and adjacent normal tissues. Immunohistochemistry was used to determine the expression of hOGG1 and p53.
There was no difference of average 8-OHdG/106dG DNA level either between HG-SOC (27.8 ± 8.9), LG-SOC (25.2 ± 7.4) and benign serous cystadenoma (26.5 ± 7.7, p = 0.35); or between the tumor-adjacent normal tissue of HG-SOC (18.8 ± 5.2), LG-SOC (21.4 ± 6.5), benign serous cystadenoma (20.5 ± 9.1) and non-tumor ovary (21.6 ± 4.9, p = 0.62). The 8-OHdG/106dG level was significantly higher in tumor comparing to that in matched normal tissue adjacent to carcinoma in HG-SOC (1.52 ± 0.52, p = 0.02), but not in LG-SOC or benign serous cystadenoma. Increased level of 8-OHdG in tumor DNA was an independent factor of overall survival in serous ovarian carcinoma upon multivariate analysis (p < 0.01). Increased level of 8-OHdG in tumor DNA indicates poorer overall and progression-free survival durations than counterparts (47.3 vs 105.7 months and 13.5 vs 45.3 months, respectively). Protein levels of hOGG1 were remarkably decreased in HG-SOC (p < 0.01), but not in LG-SOC and serous cystadenoma compared with the tissue adjacent to carcinoma. A positive result on p53 immunostaining was associated with lower hOGG1 expression in HG-SOC (p = 0.04).
Increased 8-OHdG level and decreased expression of hOGG1 in tumor were found in HG-SOC but not LG-SOC. Increased 8-OHdG level in tumor DNA was significantly associated with poorer overall survival and progression-free survival in serous ovarian carcinoma.
氧化损伤和 DNA 修复功能障碍与癌症的发生有关。8-OHdG 是主要的氧化 DNA 加合物之一。本研究旨在探讨 8-OHdG 及其关键修复基因 hOGG1 的表达是否在两种类型的浆液性卵巢癌中发挥独特作用。
检测 48 例高级别乳头状浆液性癌(HG-SOC)、24 例低级别乳头状浆液性癌(LG-SOC)、20 例浆液性囊腺瘤和 16 例非肿瘤对照卵巢中肿瘤和配对肿瘤旁正常组织的 DNA 中 8-OHdG 水平。Cox 比例风险模型和对数秩检验用于评估两种浆液性癌中 8-OHdG 水平与患者生存之间的关系。实时聚合酶链反应和蛋白质免疫印迹用于检测肿瘤和相邻正常组织中 hOGG1 mRNA 和蛋白水平。免疫组织化学用于确定 hOGG1 和 p53 的表达。
HG-SOC(27.8±8.9)、LG-SOC(25.2±7.4)和良性浆液性囊腺瘤(26.5±7.7,p=0.35)之间的平均 8-OHdG/106dG DNA 水平或 HG-SOC 肿瘤旁正常组织(18.8±5.2)、LG-SOC(21.4±6.5)、良性浆液性囊腺瘤(20.5±9.1)和非肿瘤卵巢(21.6±4.9,p=0.62)之间的平均 8-OHdG/106dG DNA 水平均无差异。HG-SOC 中肿瘤与配对癌旁正常组织相比,8-OHdG/106dG 水平显著升高(1.52±0.52,p=0.02),但 LG-SOC 或良性浆液性囊腺瘤中无差异。多因素分析显示,肿瘤 DNA 中 8-OHdG 水平升高是浆液性卵巢癌总生存的独立因素(p<0.01)。肿瘤 DNA 中 8-OHdG 水平升高提示总生存和无进展生存时间较短(分别为 47.3 个月和 13.5 个月,105.7 个月和 45.3 个月)。与癌旁组织相比,HG-SOC 中 hOGG1 蛋白水平显著降低(p<0.01),但在 LG-SOC 和浆液性囊腺瘤中无差异。HG-SOC 中 p53 免疫染色阳性与 hOGG1 表达降低相关(p=0.04)。
HG-SOC 中发现肿瘤中 8-OHdG 水平升高和 hOGG1 表达降低,但 LG-SOC 中未发现。肿瘤 DNA 中 8-OHdG 水平升高与浆液性卵巢癌总生存和无进展生存时间较短显著相关。